Flagship Pioneering related stories
All articles and analysis
Retired Nestle CTO Catsicas backs Incredible Foods, also joins boardBoston-based Incredible Foods Inc, a maker of plant-based allergy-friendly foods, has raised an undisclosed amount of funding. The investor is Dr. Stefan Catsicas, who recently retired as chief technology officer of Nestlé S.A. Catsicas will be investing via his private investment firm Skyviews Life Science Ltd. In addition to the investment, Catsicas and Melanie Kahn will join Incredible Foods' board of directors. Also, Incredible Foods has named Dr. Joseph Speroni as chief technology officer. Incredible Foods is backed by Winona Capital, Flagship Pioneering and Polaris Capital.
- KSQ Therapeutics rakes in $80 mln Series C
Cambridge, Massachusetts-based drug developer KSQ Therapeutics has secured $80 million in Series C financing. The investors included Baillie Gifford, Cowen Healthcare Investments, Invus, Lilly Asia Ventures, Flagship Pioneering, Polaris Partners, ARCH Venture Partners and Alexandria Equities.
- Indigo locks in $250 mln Series E
Boston-based Indigo Ag Inc, which is focused on "harnessing nature to help farmers sustainably feed the planet," has secured $250 million in Series E funding. The investors included Baillie Gifford, Investment Corporation of Dubai, the Alaska Permanent Fund and Flagship Pioneering.
- Otsuka completes Visterra acquisition for about $430 mln
Otsuka has closed its previously announced acquisition of Visterra, a developer of antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases, for about $430 million in cash. Visterra's backers included Polaris Partners, Flagship Pioneering, the Bill and Melinda Gates Foundation, MRL Ventures Fund, Vertex Ventures HC, Temasek Holdings, Lux Capital, Alleghany Financial Group Ventures, CTI Life Sciences Fund and Alexandria Equities.
